123 related articles for article (PubMed ID: 1844251)
1. Biological significance of gene amplification in carcinogenesis.
Terada M; Sakamoto H; Ohmura Y; Tsuruta H; Akiyama N; Sasaki H; Katoh M; Hattori Y; Yoshida T
Princess Takamatsu Symp; 1991; 22():371-80. PubMed ID: 1844251
[TBL] [Abstract][Full Text] [Related]
2. Amplified genes in cancer in upper digestive tract.
Yoshida T; Sakamoto H; Terada M
Semin Cancer Biol; 1993 Feb; 4(1):33-40. PubMed ID: 8095412
[TBL] [Abstract][Full Text] [Related]
3. Biological significance of the hst-1 gene.
Terada M; Yoshida T; Sakamoto H; Miyagawa K; Katoh O; Hattori Y; Sugimura T
Princess Takamatsu Symp; 1989; 20():71-80. PubMed ID: 2535108
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical detection of K-sam protein in stomach cancer.
Hattori Y; Itoh H; Uchino S; Hosokawa K; Ochiai A; Ino Y; Ishii H; Sakamoto H; Yamaguchi N; Yanagihara K; Hirohashi S; Sugimura T; Terada M
Clin Cancer Res; 1996 Aug; 2(8):1373-81. PubMed ID: 9816310
[TBL] [Abstract][Full Text] [Related]
5. High incidence of coamplification of hst-1 and int-2 genes in human esophageal carcinomas.
Tsuda T; Tahara E; Kajiyama G; Sakamoto H; Terada M; Sugimura T
Cancer Res; 1989 Oct; 49(20):5505-8. PubMed ID: 2529025
[TBL] [Abstract][Full Text] [Related]
6. [Oncogenes in human gastric carcinoma].
Tahara E
Gan To Kagaku Ryoho; 1989 Jun; 16(6):2149-55. PubMed ID: 2544146
[TBL] [Abstract][Full Text] [Related]
7. Amplification of c-myc, K-sam, and c-met in gastric cancers: detection by fluorescence in situ hybridization.
Hara T; Ooi A; Kobayashi M; Mai M; Yanagihara K; Nakanishi I
Lab Invest; 1998 Sep; 78(9):1143-53. PubMed ID: 9759658
[TBL] [Abstract][Full Text] [Related]
8. GST pi gene is frequently coamplified with INT2 and HSTF1 proto-oncogenes in human breast cancers.
Saint-Ruf C; Malfoy B; Scholl S; Zafrani B; Dutrillaux B
Oncogene; 1991 Mar; 6(3):403-6. PubMed ID: 1826346
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of hst-1 gene amplification in primary esophageal carcinomas and its relationship to other prognostic factors.
Shiga C; Shiga K; Hirayama K; Katayama M; Nishihira T; Mori S
Anticancer Res; 1994; 14(2B):651-6. PubMed ID: 8010723
[TBL] [Abstract][Full Text] [Related]
10. BCL-1 participates in the 11q13 amplification found in breast cancer.
Theillet C; Adnane J; Szepetowski P; Simon MP; Jeanteur P; Birnbaum D; Gaudray P
Oncogene; 1990 Jan; 5(1):147-9. PubMed ID: 2181375
[TBL] [Abstract][Full Text] [Related]
11. [Molecular mechanisms of carcinogenesis in human stomach cancer: K-sam gene].
Yoshida K; Toge T; Kuniyasu H; Yasui W; Tahara E
Nihon Rinsho; 2001 Apr; 59 Suppl 4():53-9. PubMed ID: 11424439
[No Abstract] [Full Text] [Related]
12. Expression of fibroblast growth factor gene family and its receptor gene family in the human upper gastrointestinal tract.
Iida S; Katoh O; Tokunaga A; Terada M
Biochem Biophys Res Commun; 1994 Mar; 199(3):1113-9. PubMed ID: 7511892
[TBL] [Abstract][Full Text] [Related]
13. Significance of int-2/hst-1 coamplification as a prognostic factor in patients with esophageal squamous carcinoma.
Kitagawa Y; Ueda M; Ando N; Shinozawa Y; Shimizu N; Abe O
Cancer Res; 1991 Mar; 51(5):1504-8. PubMed ID: 1997190
[TBL] [Abstract][Full Text] [Related]
14. High-throughput tissue microarray analysis of 11q13 gene amplification (CCND1, FGF3, FGF4, EMS1) in urinary bladder cancer.
Zaharieva BM; Simon R; Diener PA; Ackermann D; Maurer R; Alund G; Knönagel H; Rist M; Wilber K; Hering F; Schönenberger A; Flury R; Jäger P; Fehr JL; Mihatsch MJ; Gasser T; Sauter G; Toncheva DI
J Pathol; 2003 Dec; 201(4):603-8. PubMed ID: 14648664
[TBL] [Abstract][Full Text] [Related]
15. D11S287, a putative oncogene on chromosome 11q13, is amplified and expressed in squamous cell and mammary carcinomas and linked to BCL-1.
Lammie GA; Fantl V; Smith R; Schuuring E; Brookes S; Michalides R; Dickson C; Arnold A; Peters G
Oncogene; 1991 Mar; 6(3):439-44. PubMed ID: 2011398
[TBL] [Abstract][Full Text] [Related]
16. Isolation of the complementary DNA encoding a mouse heparin-binding growth factor receptor with the use of a unique kinase insert sequence.
Katoh O; Hattori Y; Sasaki H; Sakamoto H; Fujimoto K; Fujii T; Sugimura T; Terada M
Cancer Res; 1993 Mar; 53(5):1136-41. PubMed ID: 8382556
[TBL] [Abstract][Full Text] [Related]
17. Preferential expression of the third immunoglobulin-like domain of K-sam product provides keratinocyte growth factor-dependent growth in carcinoma cell lines.
Ishii H; Hattori Y; Itoh H; Kishi T; Yoshida T; Sakamoto H; Oh H; Yoshida S; Sugimura T; Terada M
Cancer Res; 1994 Jan; 54(2):518-22. PubMed ID: 8275490
[TBL] [Abstract][Full Text] [Related]
18. Decrease of c-erbB-2 and c-myc RNA levels in tamoxifen-treated breast cancer.
Le Roy X; Escot C; Brouillet JP; Theillet C; Maudelonde T; Simony-Lafontaine J; Pujol H; Rochefort H
Oncogene; 1991 Mar; 6(3):431-7. PubMed ID: 1707153
[TBL] [Abstract][Full Text] [Related]
19. Proto-oncogene amplification and human breast tumor phenotype.
Adnane J; Gaudray P; Simon MP; Simony-Lafontaine J; Jeanteur P; Theillet C
Oncogene; 1989 Nov; 4(11):1389-95. PubMed ID: 2554239
[TBL] [Abstract][Full Text] [Related]
20. Intratumoral heterogeneity of hst-1 gene amplification in esophageal carcinoma with reference to DNA stem line heterogeneity.
Chikuba K; Saito T; Uchino S; Inomata M; Kobayashi M
Jpn J Clin Oncol; 1995 Dec; 25(6):229-33. PubMed ID: 8523818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
